Illness	Number of cases
Hyperplasia of prostate (N40)	334
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	264
Malignant neoplasm of prostate (C61)	252
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	126
Calculus of kidney and ureter - Calculus of kidney (N20.0)	100
Calculus of kidney and ureter - Calculus of ureter (N20.1)	97
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	87
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2)	43
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1)	40
Obstructive and reflux uropathy (N13.3)	40

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	1.050
Surgical removal or destruction of prostatic tissue through the urethra (5-601.72)	411
X-rays of the kidney and urinary tract with contrast medium (3-13d.5)	395
Insertion, exchange or removal of a ureteral stent (8-137.00)	321
Insertion, exchange or removal of a ureteral stent (8-137.10)	288
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	230
Computed tomography of the abdomen with contrast medium (3-225)	178
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41)	151
Surgical incision into the ureter or removal of a stone during an open operation or endoscopy (5-562.4)	132
(9-984.7)	128

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2291

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
63	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
35	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
29	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Doctoral supervision
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies